Localized skin‐limited blastic plasmacytoid dendritic cell neoplasm
Immunohistochemical analysis showed cells that were positive for CD4, CD56, CD123, SPIB, TdT, and negative for MNDA (Figure 4), which supported the diagnosis of blastic plasmacytoid dendritic-cell neoplasm (BPDCN). The clinical features and evolution consist of two main patterns: (A) Indolent onset...
Saved in:
Published in | EJHaem Vol. 3; no. 2; pp. 560 - 562 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
John Wiley & Sons, Inc
01.05.2022
John Wiley and Sons Inc Wiley |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Immunohistochemical analysis showed cells that were positive for CD4, CD56, CD123, SPIB, TdT, and negative for MNDA (Figure 4), which supported the diagnosis of blastic plasmacytoid dendritic-cell neoplasm (BPDCN). The clinical features and evolution consist of two main patterns: (A) Indolent onset dominate by skin lesions followed by tumor dissemination (70–90%) and (B) Acute leukemia features with systemic involvement from the beginning (10-30%) [ 1, 2]. 18(F)–FDG-PET-CT imaging show lesion with oval morphology and well-defined borders (44 × 18 × 53 mm) with pathological uptake ACKNOWLEDGMENTS This work was supported by grants from the Instituto de Salud Carlos III (ISCIII) of the Spanish Ministry of Economy and Competence (MINECO, FEDER, RTICC ISCIII, and Centro de Investigación Biomédica en Red Cáncer - CIBERONC) (SAF2013-47416-R, RD06/0020/0107-RD012/0036/0060, and Plan Nacional I+D+I: |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 2688-6146 2688-6146 |
DOI: | 10.1002/jha2.383 |